发明名称 |
Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders |
摘要 |
Compounds of formula (1) are described, wherein q is zero or the integer 1, 2 or 3; R which when present may be attached to any available carbon or nitrogen atom of the bicyclic heteroaromatic ring of formula (1) is an atom or group -L<3>(Alk<3>)wL<4>(R<8>)u; X is an O atom or a S(O)m atom or group in which m is zero or the integer 1 or 2 or an NR group; Y is a N atom or a CR<1a >group in which R<1a >is a group R or a group R<1>; R<1 >which may he on any available carbon atom of the bicyclic heteroaromatic ring of formula (1) is a hydrogen atom or a group -Alk<1>L<1>CyAlk<2>L<2>D; provided that at least one but not both of R<1 >and R<1a >is the group -Alk<1>L<1>CyAlk<2>L<2>D. The compounds are potent inhibitors of the interaction between CCR-3 and it chemokine ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders in which inhibition of this interaction can have a beneficial effect. |
申请公布号 |
AU7995801(A) |
申请公布日期 |
2002.03.04 |
申请号 |
AU20010079958 |
申请日期 |
2001.08.16 |
申请人 |
CELLTECH R AND D LIMITED |
发明人 |
DAVID ALAN OWEN;ALAN FINDLAY HAUGHAN;DUNCAN BATTY;ALISTAIR GEORGE DRAFFAN;HANNAH JAYNE KENDALL;SARAH LOUISE MELLOR |
分类号 |
A61K31/452;A61K31/4525;A61K31/4535;A61K31/454;A61P29/00;A61P37/00;C07D401/12;C07D405/12;C07D405/14;C07D409/12;C07D413/12;C07D417/12 |
主分类号 |
A61K31/452 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|